These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8998787)

  • 21. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
    Goldschmidt M; Landzberg BR; Frishman WH
    J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute haemodynamic effects of nicorandil in patients with chronic severe regurgitant valvular lesions.
    Yadav R; Bhargava B; Aggarwal R; Narang R; Chopra A; Sapra R; Manchanda SC
    Indian Heart J; 1998; 50(2):173-8. PubMed ID: 9622984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An ATP-sensitive potassium (KATP) channel opener, nicorandil, lowers the threshold for ischemic preconditioning in barbital-anesthetized dogs.
    Mizumura T; Saito S; Ozawa Y; Kanmatsuse K; Gross GJ
    Heart Vessels; 1997; Suppl 12():175-7. PubMed ID: 9476575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nicorandil, a potassium channel agonist].
    Gerson C
    Soins; 1996 Nov; (610):61. PubMed ID: 9016185
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of nicorandil preconditioning on membrane dystrophin.
    Shojima T; Hayashida N; Nishi A; Takagi K; Hori H; Yoshikawa K; Aoyagi S
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):472-9. PubMed ID: 16859916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.
    Sakata Y; Kodama K; Ishikura F; Komamura K; Hasegawa S; Sakata Y; Hirayama A
    Jpn Circ J; 1997 May; 61(5):455-8. PubMed ID: 9192246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving Issues in the Treatment of Ischaemic Heart Disease: The Potassium Channel Openers. Symposium proceedings. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Jul; 14 Suppl B():1-52. PubMed ID: 8103740
    [No Abstract]   [Full Text] [Related]  

  • 28. K(+)-channel openers protect the myocardium against ischemia-reperfusion injury.
    Popescu LM; Musat S; Trifan OC; Leabu M; Tigaret CM; Popescu M; Popescu A; Hinescu ME; Moraru II; Das DK
    Ann N Y Acad Sci; 1994 Jun; 723():398-400. PubMed ID: 8030895
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
    Roland E
    Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving Issues in the Treatment of Angina Pectoris. Nicorandil: The 1st Potassium-Channel Activator in Ischemic Heart Disease. Proceedings of an International Workshop. Taormina, Sicily, May 8-12, 1991.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S1-108. PubMed ID: 1282167
    [No Abstract]   [Full Text] [Related]  

  • 32. [Successful treatment of intraoperative myocardial ischemia with nicorandil].
    Kawamura S; Hayashida M; Orii R; Sawamura S; Komatsu K; Ito N; Kuzumi E; Hanaoka K
    Masui; 1997 Apr; 46(4):531-7. PubMed ID: 9128027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of anti-anginal and/or coronary vasodilator drugs on coronary as well as systemic hemodynamics, myocardial blood flow distribution during halothane anesthesia in dogs (author's transl)].
    Kohyama A
    Masui; 1981 Feb; 30(2):127-40. PubMed ID: 7277675
    [No Abstract]   [Full Text] [Related]  

  • 34. New antianginal therapy. First International Symposium on Nicorandil, a new antianginal agent. Honolulu, Hawaii, U.S.A, January 24-26, 1986.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S1-129. PubMed ID: 2447413
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of nicorandil on regional cerebral oxygen saturation].
    Kasuya Y; Dohi S
    Masui; 1997 Oct; 46(10):1305-9. PubMed ID: 9369043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the relation between collateral development and the effects of antianginal drugs--effects of nitroglycerin and 2-nicotinamidethyl nitrate on collateral circulation (author's transl)].
    Inou T
    Fukuoka Igaku Zasshi; 1981 Aug; 72(8):440-67. PubMed ID: 6457779
    [No Abstract]   [Full Text] [Related]  

  • 37. Coronary hemodynamics in heart failure and effects of therapeutic interventions.
    Chatterjee K
    J Card Fail; 2009 Mar; 15(2):116-23. PubMed ID: 19254670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicorandil for angina.
    Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adalat effects on clinical course of coronary heart disease, peripheral circulation and myocardial perfusion in patients with stenosing coronary atherosclerosis].
    Garganeeva AA; Tepliakov AT; Chernov VI; Braslavskaia TG
    Ter Arkh; 1998; 70(9):61-3. PubMed ID: 9821229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of a novel KATP channel opener JTV-506 on myocardial infarct size of isolated rat heart].
    Jia DL; Zheng XW; Qi GX; Hu J; Zeng DY
    Yao Xue Xue Bao; 2000 Oct; 35(10):743-6. PubMed ID: 11372439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.